Cargando…
Unexplained pancytopenia in acute myeloid leukemia treatment
Certain histopathological findings have been described in acute myeloid leukemia (AML) patients during treatment that define the hematologic outcomes. Such entities as bone marrow necrosis and hemophagocytic lymphohistiocytosis have been reported. These often result in severe pancytopenia.
Autores principales: | Ezekwudo, Daniel, Lupak, Oleksandra, Vaddepally, Raju, Gbadamosi, Bolanle, Kuriakose, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099047/ https://www.ncbi.nlm.nih.gov/pubmed/30147892 http://dx.doi.org/10.1002/ccr3.1570 |
Ejemplares similares
-
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
por: Ezekwudo, Daniel E., et al.
Publicado: (2017) -
Sarcoidosis as an unusual cause of unexplained pancytopenia
por: Raymond, Caitlin, et al.
Publicado: (2023) -
Acute Myeloid Leukemia as the Main Cause of Pancytopenia in Iranian Population
por: Jalaeikhoo, Hasan, et al.
Publicado: (2017) -
Effective Immunotherapy in Bone Marrow Metastatic Melanoma Presenting with Disseminated Intravascular Coagulopathy
por: Gbadamosi, Bolanle, et al.
Publicado: (2018) -
Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Case Report and Review of the Literature
por: Ezekwudo, Daniel E., et al.
Publicado: (2017)